Disease Therapies

Logo PR Newswire
HealthPress Release2023-03-20 12:40:00
Dr. Raphael Kellman Gives Hope to Patients; Emphasizes Value of Innovative Therapies During Autoimmune Awareness Month NEW YORK, March 20, 2023 /PRNewswire/...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-20 11:06:00
Cure Rare Disease (CRD) - a nonprofit biotechnology company focused on developing treatments for ultra-rare diseases - announces the appointment of leading...

Logo CNBC
HealthBy Annika Kim Constantino2023-03-20 18:53:03
Key Points U.S. Food and Drug Administration staff on Monday said Biogen's investigational ALS drug may have a "clinical benefit" on a rare and aggressive...

Logo EIN Presswire
Liver Disease market The growth of the liver disease treatment market is attributed to increase in prevalence of liver diseases, rise in drug discovery and...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-03-20 12:30:00
Clinical trials and effective treatment protocols rely on comprehensive data on rare disease demographics and treatments. Rare diseases affect hundreds of...

Logo GlobeNewswire
SciencePress Release2023-03-20 12:00:00
Panel discussion to be held on Saturday, March 25 at 12:00pm ET / 11:00am CT / 9:00am PT. SAN DIEGO, March 20, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc....

Logo GlobeNewswire
SciencePress Release2023-03-20 12:28:00
TORONTO, March 20, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (Revive or the Company) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-20 11:55:00
Researchers can now access over 8,000 patient-derived xenografts (PDX), cell-derived xenografts (CDX), organoids and cell lines from Scientist.com's...

Logo EIN Presswire
SciencePress Release2023-03-20 14:45:00
CDD Vault research informatics system African researchers to receive CDD Vault resource for neglected disease drug discovery collaborations

Logo GlobeNewswire
SciencePress Release2023-03-20 11:30:00
- Company Presents Overviews of ACHIEVE and DELIVER Global Clinical Trials with Data Anticipated from Both Studies in the Second Half of 2023 - - FORCE...

Logo Benzinga
HealthBy Vandana Singh2023-03-20 11:27:42
Novartis AG NVS has presented new data on Zolgensma (onasemnogene abeparvovec), a one-time gene therapy for the treatment of spinal muscular atrophy (SMA)....

Logo GlobeNewswire
SciencePress Release2023-03-20 12:00:00
Results demonstrate that XT-150 can facilitate improved knee function during walking gait, which persists to 180 days following a single injection NEW YORK,...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-03-20 14:03:00
After traveling the world interviewing medical professionals, alternativehealth experts, commentators, whistleblowers, and physiciansto document the many...

Logo EIN Presswire
Autologous Cell Therapy Market 2023 This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the...

Logo EIN Presswire
HealthPress Release2023-03-20 11:08:18
Plasma Therapy Market Forecast SEATTLE, WASHINGTON, UNITED STATES, March 20, 2023 / EINPresswire.com / -- Edition: 2023

Logo PR Newswire
HealthPress Release2023-03-21 00:00:00
ROCKVILLE, Md. and SUZHOU, China, March 20, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company...

Logo GlobeNewswire
SciencePress Release2023-03-20 12:00:00
CAPE CANAVERAL, Fla., March 20, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of...

Logo PR Newswire
HealthPress Release2023-03-20 08:30:00
STEVENAGE, England, March 20, 2023 /PRNewswire/ -- New data* presented at the 2023 Osteoarthritis Research Society International (OARSI) World Congress in...

Logo Benzinga
HealthBy Vandana Singh2023-03-20 14:21:15
Takeda Pharmaceutical Co Ltd TAK announced results from a Phase 2b clinical trial of TAK-279 (NDI-034858) in patients with moderate-to-severe plaque...

Logo GlobeNewswire
SciencePress Release2023-03-20 12:00:00
AC Immune at AD/PD 202 3 to Present New Clinical and Preclinical Data f rom its Precision Medicine Pipeline Ten presentations at the International Conference...